Vertex Pharmaceuticals Incorporated: Solid Sales, Prepping for Next Generation

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 1 May, 2017 by The TZ Newswire Staff

Vertex Pharmaceuticals Incorporated: Solid Sales, Prepping for Next Generation

Cystic fibrosis expert Vertex Pharmaceuticals (NASDAQ: VRTX) reported solid first-quarter earnings after the bell on Thursday and gave an update on its pipeline of next-generation drugs to treat the disease.

Metric

Q1 2017

See also
- Next Article Four Reasons Tax Cuts Could Be a Big Dud
- Previous Article Renaissance keeps making billionaires
Editorial Calender

May 2017

M T W T F S S

1 2 3 4 5 6 7

8 9 10 11 12 13 14

15 16 17 18 19 20 21

22 23 24 25 26 27 28

29 30 31

« Apr Jun »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 1 May, 2017 by The TZ Newswire Staff

Vertex Pharmaceuticals Incorporated: Solid Sales, Prepping for Next Generation

See also

Editorial Calender

Recent Tags